BackAgile Therapeutics Overview
Agile Therapeutics Inc

Agile Therapeutics Discounted Cash Flow

DCF Analysis for AGRX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.28

Current Fair Value

$1.28
15.5% Downside

Overvalued by 15.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading